Polyneuron Pharma raise CHF22.5m in Series A financing
Polyneuron Pharmaceuticals AG develops glycopolymers that mimick epitopes of autoantibodies attacking the nervous system, providing a new...
AMR: Novo Holdings funds companies with €18m
"Three additional investments into companies developing innovative novel anti-infective therapies were made in late 2018", Novo Holdings...
New target for lung fibrosis discovered
Seeking for the reason why myofibroblasts, which normally secrete collagen in response to inflammatory signals to repair tissue injury in the lungs,...
Clariant inks cellulosic biodiesel pact with ExxonMobil/REG
The companies said the goal of their partnership was to combine Clariant’s sunliquid® microbial cellulose degradation technology with REG’s...
Treating diabetes by mimicking gut bacteria effects
In Nature Chemical Biology, the international team headed by Graeme Milligan from University of Glasgow report that drugs might mimic the...
Biotechpharma UAB expanding production
Besides the expansion of its fermentation capacity to 5,000L, the CDMO added a state of the art process development laboratory to its new production...
AMR diagnostic specialist Gradientech raise $4.6m
Gradientech said it will use the proceeds from the rights issue for commercialisation of its QuickMIC™ diagnostic system. QuickMIC™ is a microfluidic...